Akili raises $30.5 million for ADHD Video Game

<p>The game, known as <em>Project: EVO</em>, makes players explore a virtual world and select certain items, while avoiding other objects.</p>

The game, known as Project: EVO, makes players explore a virtual world and select certain items, while avoiding other objects.

Akili Interactive Labs Inc. in Boston is developing a video game that is believed to have the ability to replace pills as treatment for ADHD (attention-deficit hyperactivity disorder.) They hope to run a large trial to gain approval from the FDA in 2017.

The game, known as Project: EVO, makes players explore a virtual world and select certain items, while avoiding other objects.

"There is a big need in the marketplace from parents, patients and doctors for nonpharmacological therapies for ADHD,” said Eddie Martucci, chief executive of Akili. “We’re doing work to see where [Project: EVO] will fit.”

According to the official Akili website, the gaming engine enables three separate clinical game versions for remote data-capture, with features designed for extreme patient engagement. This includes measuring sensitive data, tracking the patient’s cognitive status over time and improving these symptoms. In short, it measures everything the player does, their movement, and their focus while playing the game.

Project: EVO is currently being tested in various studies around the globe for ADHD, autism, depression, and traumatic brain injury.

Akili is hoping their new gaming medication will be available on the App store and Google play to be available for phones and tablets in 2017.

-----

Sources: WSJ, Akili Interactive

Image: Recode

Comments

More from The Daily






This Week's Digital Issue


Loading Recent Classifieds...